Skip to Content
Merck
CN
  • An evaluation of nitric oxide, folate, homocysteine levels and lipid peroxidation in postmenopausal osteoporosis.

An evaluation of nitric oxide, folate, homocysteine levels and lipid peroxidation in postmenopausal osteoporosis.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University (2013-07-06)
Veysi Akpolat, H Murat Bilgin, M Yusuf Celik, Mahmut Erdemoglu, Birgul Isik
ABSTRACT

In the current study, the risk coefficients of nitric oxide (NO), folate, homocysteine levels and lipid peroxidation in postmenopausal osteoporotic women were determined. Bone mineral density was determined by dual-energy X-ray absorptiometry. The levels of serum lipid peroxidation products such as the thiobarbituric acid adduct of malondialdehyde (MDA) were measured spectrophotometrically. Plasma folate and homocysteine (Hcy) levels were measured by enzyme chemiluminescence immunoassay. Plasma nitrite levels were measured with the Griess reaction The odds ratios and 95% Confidence Intervals (CI) of the variables MDA, folate, NO, body-mass index (BMI), menopause age and age were found significant. MDA, NO and folate variables were found statistically significant in the analysis of receiver operating charecteristic (ROCs). The areas under the curve (AUCs, 95% CI) of MDA, NO and folate were found to be statistically significant. The current study indicates that NO, MDA and folate are risk variables for postmenopausal osteoporosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Homocysteine, ≥98.0% (NT)
Supelco
Folic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Folic acid, meets USP testing specifications
Sigma-Aldrich
Folic acid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥97%
Sigma-Aldrich
Folic acid, ≥97%
Sigma-Aldrich
Folic acid, Vetec, reagent grade, ≥97%
Folic acid, European Pharmacopoeia (EP) Reference Standard